Also in this playlist...
This transcript is automatically generated
That's your -- -- wrong here -- by the sea -- sit down on a Monday morning you may not recognize the name but solaris the company could possibly affect every human beings life on the -- I'm even an exaggeration because it's in their genetic research business and it's a global reader.
Global leader in disease detection and prevention and -- separated from its parent company Applera.
Last week the company CEO Kathy Ordonez celebrated by ringing the opening bell that day at the NASDAQ and now -- but after that I was able to catch up with -- and I asked -- what we should expect.
From a a newly independent -- You probably.
I remember Celera as the company that originally sequence the human genome.
We -- research driven company but now we have a successful commercial business.
Last quarter we have revenues on the order of almost forty million dollars and -- we are.
Very close to being profitable on a non-GAAP basis.
Now when will that happen do you think.
Well we've projected that will be profitable for the fiscal year that's just sending.
OK so a couple of interesting things one it's just about the status of you being publicly traded you do you -- the NASDAQ under the three letter ticker symbol which I found interest do you account of the -- for awhile.
Never heard of that three letters CRAs you still your -- so they let you do that.
They did let us do it and we were actually quite surprised they told us that there are two other companies.
That are not four letters as well.
That's interest -- because you have four letter symbols and always in the way the NASDAQ.
Was known to tell us a little bit about solaris is that it -- the business has changed from when you were previously publicly traded -- what's the transition been like.
Well we -- we've moved from focusing just on research.
Two commercializing products and services that are used for personalizing disease management.
We have a business called Berkeley heart lab.
That is involved in providing products and services to help people manage their cardiovascular disease.
That sounds like you know on an unfortunate to say growth does this mean that there's more and more than that type of thing happening obviously it says the baby boomer generation gets older beautiful logic we hear from health care companies all the -- -- -- Absolutely.
Because of the knowledge that Celera and other companies have gained.
About how human variability -- relates to disease.
We can offer.
Proprietary diagnostic testing that allows you to customize.
Treatment options -- in conjunction with your position.
Very interest in human very abilities -- who -- -- -- How about the cost Sutton how much of the cost of the second test going up obviously some would benefit your -- and we hear about all the time political dialogue for example health care costs going up to an extent of costs rise.
Well costs are rising but you have to look at this in -- global perspective.
New tests like our cat six test actually contribute to reducing the overall cost of health care mean.
And the the economy going up and down for.
For of the average American obviously has an effect what effect does that have on your business.
Well and there is some seasonality.
To solaris business.
But overall if you have cardiovascular disease yet you need to manage it got -- so.
It's not something that we expect to impact the overall business -- -- done as they're nesting beaches and I good luck on the NASDAQ which is three letters three letters that's all we need.
Kathy Ordonez the CEO at -- Very much for joining us we appreciate it --
Filter by section